Bloomberg Intelligence cover image

Intel to Sell 51% Altera Stake to Silverlake

Bloomberg Intelligence

CHAPTER

Pfizer's Strategic Moves in Obesity Treatments

This chapter examines Pfizer's strategic approach to obesity treatments and their development of a new oral GLP-1 medication for diabetes. It also discusses market release timelines and the impact of competitive data from Chinese biotechs on Pfizer's position.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner